The pharmacological actions of these oxicams are related to inhibition of cyclooxygenase (Cox), a key enzyme of prostaglandine biosynthesis at the site of inflammation. 4) Lx is distinguished from established oxicams by a relatively short elimination half-life, which may be advantageous from a tolerability stand point. 5) Mx is suggested to be a selective Cox-2 inhibitor. 4) The official methods for the determination of Tx and Mx are non aqueous titration with perchloric acid, determining the end point potentiometrically.
2) Lx is not official in any pharmacopoeia and a literature survey revealed that few attempts have been made as stability indicating methods, spectrophotometric, 6) electrochemical 7) and few HPLC [8] [9] [10] methods were reported for its determination. For Tx, different methods were reported including spectrophotometric, 6, [11] [12] [13] fluorimetric, [13] [14] [15] infrared, 16) electrochemical [17] [18] [19] and HPLC 8, 20) methods. For Mx, spectrophotometric, 6, 13, [21] [22] [23] fluorimetric, 13, 24) electrochemical 25, 26) and HPLC 8, 23, 27, 28) methods were reported. Among the various methods available for the determination of drugs, spectrophotometry and spectrofluorimetry continue to be very popular, because of their simplicity, specificity and low cost. This study presents a new spectrophotometric and spectrofluorimetric methods for the assay of Lx, Tx and Mx. The methods are based on derivatization with 7-chloro-4-nitrobenz-2-oxa-1,3-diazole (NBD-Cl) which is highly sensitive and selective reagent for primary and secondary amines. NBD derivatives are usually determined fluorimetrically, 29, 30) however, photometric detection has also occasionally been used. 31, 32) The aim of this study was to optimize the reaction between the alkaline hydrolytic products of the three studied drugs and NBD-Cl.
The applicability of the developed methods was evaluated through the determination of Lx, Tx and Mx in bulk powder, in laboratory prepared mixtures containing different percentages of degradation products as well as in pharmaceutical dosage forms.
line Degradates Stock Standard Solution (Series A), (100 mg ml Ϫ1 ): About 10 mg of each of Lx, Tx and Mx were accurately weighed and separately transferred into three 100-ml conical flasks. Twenty milliliters of 2 M sodium hydroxide were added to each flask and heated in a boiling water bath for 15, 10, 30 min for Lx, Tx and Mx respectively. After cooling 2 M hydrochloric acid was added for each drug solution till the pH was adjusted to 9. Each solution was transferred quantitatively to 100-ml volumetric flask. The volume was completed to the mark with distilled water. Standard working solutions (10, 20, 40, 60, 80 , 100 mg ml Ϫ1 for Lx and Tx alkaline degradates, while 5, 10, 20, 30, 40 mg ml Ϫ1 for Mx alkaline degradate) were prepared by suitable dilution of the obtained stock solutions of standard degradates,these solutions were used for spectrophotometric method. For spectrofluorimetric method, the standard working solutions were further diluted ten times in 10-ml volumetric flasks.
Lornoxicam, Tenoxicam and Meloxicam Standard Stock Solutions (Series B), (100 mg ml Ϫ1 ): They were prepared by accurately weighing 10 mg of each of Lx, Tx and Mx powder and transferred separately into 100-ml volumetric flasks. They were dissolved in 1.0 ml of 0.1 M sodium hydroxide, 80 ml of distilled water was added for each drug and pH was adjusted to 9. Then the volume was completed to the mark with distilled water. Standard working solutions (10, 20, 40, 60, 80 , 100 mg ml Ϫ1 for Lx and Tx while 5, 10, 20, 30, 40 mg ml Ϫ1 for Mx) were prepared by appropriate dilution with distilled water. These solutions were used for spectrophotometric method. For spectrofluorimetric method, the standard working solutions were further diluted ten times in 10-ml volumetric flasks.
Analytical Procedures Spectrophotometric Method: Aliquots equivalent to 40 mg of each of Lx and Mx while 100 mg of Tx alkaline degradates were separately transferred from their working standard solutions (series A) into three test tubes. The solutions were mixed each with 1 ml of borate buffer pH 8. After addition of 0.6 ml of NBD-Cl solution (0.4% w/v), the mixtures were heated for 30 min in a boiling water bath. Then they were cooled and acidified with 0.1 ml of 0.1 M hydrochloric acid. The reaction products solutions were transferred quantitatively into three 10-ml volumetric flasks, the volume was completed to the mark with methanol. The difference in absorption spectra of the obtained solutions and blanks of their corresponding concentration similarly treated but without hydrolysis were recorded in range 350-700 nm.
Spectrofluorimetric Method: One milliliter of each of the obtained solution under "Spectrophotometric Method" were transferred into 10-ml volumetric flask and diluted with methanol. The difference in fluorescence intensity was measured at l em 535 nm using l ex 460 nm for each of the three studied drugs against its corresponding drug concentration without hydrolysis and similarly treated.
Assay of Dosage Forms An accurately weighed amount of ten tablets, capsules, or vials powder, and equivalent milliliters of six ampoules, equivalent to 40 mg of the cited drugs, were transferred into 100-ml volumetric flask, 80-ml of acetone was added and shaken for 30 min. The volume was diluted to the mark with acetone, mixed and filtered. A 25-ml of each of Lx, Tx and Mx were transferred into three 100-ml conical flasks evaporated on a boiling water bath to dryness. One milliliter of 0.1 M sodium hydroxide and 80 ml water were added for each flask. They were transferred quantitatively into three 100-ml volumetric flasks and proceed as under "Lornoxicam, Tenoxicam and Meloxicam Standard Stock Solutions" (series B). Another 25-ml of each drug was transferred separately into three 100-ml conical flask. Each solution was evaporated to dryness on a boiling water bath, 20-ml of 2 M sodium hydroxide was added and proceed as under "Lornoxicam, Tenoxicam and Meloxicam Alkaline Degradates Stock Standard Solution" (series A). The procedures were followed as under "Spectrophotometric Method", "Spectrofluorimetric Method" for spectrophotometric and spectrofluorimetric methods respectively.
Method Validation Linearity: Aliquots equivalent to 10-100 mg of Lx and Tx and equivalent to 5-40 mg of Mx were separately transferred from working standard solutions (series A) , into a series of test tubes. The procedure under "Spectrophotometric Method" was followed. The difference in absorbance was measured at 460 nm for the three studied drugs. Each measurement was recorded against its corresponding concentration without hydrolysis and similarly treated. The DA values obtained were plotted against the corresponding concentrations. The regression equations were calculated.
Spectrofluorimetrically, aliquots equivalent to 5-100 mg of Lx and Tx, while 2.5-40 mg of Mx were separately transferred from their working standard solutions (series A). The procedure was proceeded as under "Spectrofluorimetric Method". The fluorescence intensity was measured at l em 535 nm using l ex 460 nm for the three cited drugs. The difference in fluorescence intensity between each concentration and the corresponding concentration without hydrolysis and similarly treated was recorded. The DF (difference in fluorescence intensity) values obtained were plotted against the corresponding concentrations. The regression equations were calculated.
Accuracy: The previously mentioned procedures under study of linearity were repeated four times for determination of five different concentrations of pure samples of Lx, Tx and Mx. The recovery percentages and mean recoveries were calculated from their corresponding regression equations.
Precision: Intraday precision was evaluated for the three studied drugs by assaying freshly prepared solutions in triplicate at concentrations 1, 2 and 4 mg ml Ϫ1 while 0.1, 0.2 and 0.4 mg ml Ϫ1 for spectrophotometric and spectrofluorimetric methods respectively. The relative standard deviation was calculated. The interday precision of the proposed methods was calculated from assaying freshly prepared solutions in triplicate for 3 d. The relative standard deviation was then calculated.
Specificity: Aliquots equivalent to (90-10 mg) of each of Lx and Tx, while equivalent to (36.0-4.0 mg) of Mx for spectrophotometric and spectrofluorimetric methods, were separately transferred from their working standard solutions (series B) into 10-ml volumetric flasks for spectrophotometric and spectrofluorimetric methods for the three cited drugs. To the previous solutions aliquots equivalent to (10-90 mg) of Lx and Tx while equivalent to (4.0-36.0 mg) for Mx from their working standard solutions (series A). The obtained solutions contained degradates in the range of 10-90%. Then the assay was completed as under "Spectrophotometric Method", "Spectrofluorimetric Method". for spectrophotometric and spectrofluorimetric methods respectively.
Standard Addition Technique: The detailed procedures mentioned under linearity were adopted for the determination of the drugs in their dosage forms and the standard addition technique was applied to assess the accuracy of the method according USP28 guidelines. The concentrations were calculated from their corresponding regression equations.
Results and Discussion
NBD-Cl is a reagent known to react with aromatic amines through electrophilic substitution. The studied drugs Lx, Tx and Mx do not contain primary amino group, while upon hydrolysis with alkali the cleavage of weak amide group occurs with production of primary amine, 2-aminopyridine (2-AP) for Lx and Mx and 2-amino-5-methylthiazole (2-AMT) for Mx. These primary amines react with NBD-Cl and the reaction product has fluorescence intensity at l em 535 nm upon excitation with 460 nm and yellowish brown color with l max 460 nm. The proposed NBD-Cl method extend to develop a stability indicating assay for the three studied drugs. These drugs are liable to alkaline hydrolysis, the process of hydrolysis was found to be accelarated by elevating the temperature and increasing the basicity of the medium. It was found that 2 M sodium hydroxide and heating for 15, 10, 30 min for Lx, Tx and Mx respectively gave complete hydrolysis. The suggested mechanism of reaction can be interpreted as in Chart 1.
The present work depends on measuring the difference in absorbance at l 460 nm in spectrophotometric method and difference in fluorescence intensities at l em 535 nm upon excitation with l ex 460 nm of two solutions of the same concentration of each of Lx, Tx and Mx before and after complete alkaline hydrolysis. Hence, any degradation products intially present in Lx, Tx or Mx samples will be subtracted from the readings of the experiment at the corresponding wavelength after hydrolysis and the difference in absorbance before and after hydrolysis will be corresponding only to the intact drug.
The fluorescence intensity at l em 535 nm before and after hydrolysis was also applied for the determination of only intact Lx, Tx and Mx samples as any degradation product in Lx, Tx and Mx samples will be canceled.
Spectrophotometric Method The spectra of the alka-line hydrolytic products of the three studied drugs with NBD-Cl, show the same characteristic l max at 460 nm as shown in Fig. 1 . Also from these figures it is clear that, no reaction was observed between the intact drugs and NBD-Cl. So, this method was used for the stability studies of these drugs. Various parameters affecting reaction process were established, the reagent amount required was examined and it was found that 0.6 ml of 0.4% w/v of NBD-Cl reagent was enough to complete the reaction. A greater excess showed no further improvement as shown in Fig. 2 . The pH dependence of the system was studied in the range of 7.5-10.0 using buffer solutions at different pH. It was found that maximum absorbance was obtained upon using 1 ml of borate buffer pH 8 as shown in Fig. 3 .
Preliminary studies reported that the reaction rate was very slow at room temperature. In this study, the derivatization reaction was performed at different temperatures. The reaction was completed when heating in a boiling water bath for 30 min as shown in Fig. 4 .
The absorbance was influenced by the solvent used, the derivatives have maximum absorbance in methanol and it was stable in this solvent for at least 48 h in dark. Under the optimum experimental conditions the calibration curves were plotted representing the relationship between the difference in absorbance at 460 nm before and after complete alkaline hydrolysis and their corresponding concentrations of pure Lx, Tx and Mx samples. The concentration range was found to be 1-10 mg ml
Ϫ1
for each of Lx and Tx, while 0.5-4.0 mg ml Ϫ1 for Mx. The suggested method quantitatively determined the studied drugs in their bulk powder with good accuracy and preci- sion. The mean percentage recoveries were. Spectrofluorimetric Method On the same principle a spectrofluorimetric method was developed .The fluorescence spectra of alkaline hydrolytic products with NBD-Cl, show fluorescence intensity at l em 535 nm for the three cited drugs, as shown in Fig. 5 . Also, it is clear that no reaction was observed between the intact drugs with NBD-Cl.
After studying of the reaction conditions, it was found that those conditions for spectrophotometric method were optimum for spectrofluorimetric one. The calibration curves were plotted representing the relationship between the difference in fluorescence intensities at l em 535 nm using l ex 460 nm before and after alkaline hydrolysis and their corresponding concentrations of pure Lx, Tx and Mx samples.
The concentration range was found to be (50-1000 ng ml
) for each of Lx and Tx while (25-400 ng ml Ϫ1 ) for Mx. The suggested methods were quantitatively determined the three studied drugs in their bulk powder with good accuracy and precision. The mean percentage recoveries were found to be 100.3Ϯ1.1, 99.8Ϯ1.1, 100.0Ϯ1.0 for Lx, Tx and Mx respectively. As for the specificity of the methods Lx, Tx and Mx can be determined in presence of up to 90% of their alkaline degradates via the proposed methods with good accuracy and precision. The results are shown in Table 1 .
The proposed methods were successfully applied for the analysis of the studied drugs in their pharmaceutical dosage forms, Table 2 . The validity was assessed by applying the standard addition technique, the results are shown in Table 3 .
Statistical comparison showed that there is no significant difference between the results obtained from the proposed methods and the reported or official methods. The proposed 656 Vol. 54, No. 5 methods were found to be accurate and precise since the calculated t and F values are less than the tabulated ones as shown in Table 4 . The results of assay validation are represented in Table 5 .
Conclusion
The proposed spectrophotometric and spectrofluorimetric methods provided sensitive, specific, inexpensive and stability indicating analytical procedures for the determination of Lx, Tx and Mx. They can readily be applied for routine quality control testing and drug stability monitoring. Moreover, the spectrofluorimetric method having range sensitive enough for suggesting the ability of application of the method in biological samples, where low concentration level are found.
